Catheter ablation for ventricular tachycardia
H S Lim1, C B Singleton, M Alasady
1Department of Cardiovascular Medicine, Flinders Medical Centre, Cardiovascular Research Centre, Department of Cardiology, Royal Adelaide Hospital and the Discipline of Physiology, School of Molecular and Biomedical Science, University of Adelaide and School of Medicine, Flinders University, Adelaide, South Australia, Australia.
Insights
Catheter ablation offers a potentially curative treatment for ventricular tachycardia (VT) in patients with structurally normal hearts. Recent advancements enhance its efficacy, providing a valuable alternative to implantable cardioverter defibrillators for managing these arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Sudden cardiac death from ventricular arrhythmias is a leading cause of mortality.
- Implantable cardioverter defibrillators reduce mortality but do not cure arrhythmias.
- Ventricular tachycardia in structurally normal hearts often carries a lower sudden death risk.
Purpose of the Study:
- To review recent advancements in catheter ablation for ventricular tachycardia (VT).
- To discuss the clinical utility and patient selection for VT ablation.
- To highlight the growing role of ablation in managing ventricular arrhythmias.
Main Methods:
- Review of recent literature on catheter ablation techniques for VT.
- Analysis of advancements in lesion creation and 3D mapping.
- Discussion of mapping unstable VT and treatment efficacy.
Main Results:
- Catheter ablation is a potentially curative option for VT in select patients.
- Technological advances have improved ablation efficacy and mapping accuracy.
- Ablation is increasingly utilized for ventricular arrhythmias, including unstable VT.
Conclusions:
- Recent advances have renewed interest in catheter ablation for VT.
- Catheter ablation offers a curative approach for VT in structurally normal hearts.
- Understanding clinical utility and referral criteria is crucial for optimal patient management.
Abstract:
Sudden cardiac death due to ventricular arrhythmias remains the most common cause of death in developed nations. Implantable cardioverter defibrillators have been shown to improve mortality in high-risk groups for ventricular tachyarrhythmias, but they are not curative, with the risk of arrhythmia recurrence remaining unaltered. It is also important to remember that ventricular tachycardia (VT) in the setting of a structurally normal heart is often not associated with an increased risk of sudden death and catheter ablation is a potentially curative procedure in this cohort. Recent advances in catheter ablation for VT have increased the efficacy in creating adequate lesions, accurate three-dimensional maps and mapping haemodynamically unstable VT, all of which have increased the utility of this modality in the treatment of ventricular arrhythmias. In this article, we review the recent advances that have fuelled renewed interest in catheter ablation of VT, its clinical utility and who should be referred.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Dysrhythmias II: Classification of Tachyarrhythmias


